Results for the Quarter Ended on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.2 pts less than its Trading & Distributors peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Vaxfab Enterprises reported Q2 FY26 revenue from operations of ₹5,504.09 lakhs, a sharp jump from ₹1,066.93 lakhs in the same quarter last year. However, the company continued to post losses, with a net loss of ₹224.99 lakhs for the quarter, though this was much narrower than the ₹822.72 lakh loss in Q2 FY25. For the half year, the loss came in at ₹186.24 lakhs versus ₹764.22 lakhs a year earlier, with negative EPS of ₹2.217. Trade receivables surged dramatically to ₹8,238 lakhs from ₹2,117 lakhs as at March 2025, while inventories fell sharply to just ₹9 lakhs. Total assets declined to ₹9,075.90 lakhs and equity slipped to ₹1,157 lakhs. Despite the losses, the company generated positive operating cash flow of ₹78.16 lakhs.
Shareholders should note the continued losses and negative EPS, though the narrowing of losses and strong revenue growth are encouraging signs. The sharp rise in trade receivables warrants attention as it indicates large amounts are owed by customers, while the company's working capital and debt position will need to be monitored closely.